US FDA’s Infant Formula Regulatory Authority Doesn’t Reach ‘All That Needs To Be Fixed’
“This system is fundamentally prone to supply chain disruptions with so few manufacturers,” says Mark Moorman, FDA Office of Food Safety director. In FDLI presentation, he acknowledges delicate balance in stemming distribution of potentially contaminated power formula while sustaining supply.
You may also be interested in...
Agency proposal, now under HHS review, further reduces chances of losing another whistleblower complaint by taking ORA out of the loop, while proposing a new name for its slimmed-down field organization: Office of Inspections and Investigations. Meanwhile, an agency veteran, Michael Rogers, will lead the revamped organization as associate commissioner.
Herbalife’s five sales regions leaving behind pandemic impact at different speeds; Abbott’s 15.5% nutritional sales growth didn’t overcome more than 30% slump in diagnostics sales; ChromaDex steady sales growth for most of past three years continues with 14% in latest quarter; USANA and Mannatech results slump.
Lingo’s target “is to do something that not a lot of well-established health care companies do, which is to create a product that's really targeting a healthy population and a healthy population that wants to stay healthy,” says CEO Robert Ford.